SHCBP1 was found to enhance prostate cancer cell development, metastasis, and mitosis, with the SHCBP1—polo‐like kinase 1 (PLK1)—CDC25C axis playing a key role in promoting tumorigenesis. Here, CDC25C is linked to prostate carcinoma.